Kineta, Inc

Aura Biosciences is a biotechnology company based in Brighton, MA, that is dedicated to revolutionizing cancer treatment through its targeted oncology platform. Using Virus-Like Particles (VLPs), the company develops Virus-Like Drug Conjugates (VDCs) that can effectively target a wide range of solid tumors, with a particular focus on ocular and urologic oncology. With a mission to provide new and improved treatment options for patients, Aura Biosciences is specifically addressing the urgent need for early intervention in ocular cancer, such as choroidal melanoma. By leveraging their innovative VDC platform, the company aims to develop a potential new standard of care that preserves vision and improves patient outcomes.Generated from the website

X4 Pharmaceuticals, Inc is a biopharmaceutical company based in Allston, MA, specializing in the development of novel therapies for individuals with chronic neutropenic disorders. Leveraging their expertise in diseases of the immune system and CXCR4 biology, they aim to bring innovative treatments to people suffering from these conditions. Their lead product candidate, mavorixafor, is designed to enhance immune system function by enabling the mobilization of immune cells from the bone marrow into the bloodstream. With a focus on progress and a commitment to patients, X4 Pharmaceuticals is dedicated to advancing therapies that can make a difference in the lives of those affected by chronic neutropenic disorders.Generated from the website

AB Biosciences is a leading biotechnology company based in Boston, MA, specializing in the development of niche antibody-based biologics. With a team of top-notch protein engineering experts, they are dedicated to advancing therapeutic antibody engineering and neo CAR-T gene therapy. Their research projects include the development of a high-affinity PD-L1 decoy protein, massive antibody mining for accelerating R&D timelines, and the engineering of non-antibody biologics for blocking SARS-CoV-2 binding to ACE2. AB Biosciences is committed to pushing the boundaries of biotechnology and making significant contributions to the field of immunotherapy.Generated from the website